Wenjun Liu

发表

Clinicopathological significance of CEACAM1 gene expression in breast cancer.

Jing-zhong Sun, R. Ma, X. Qu, 2011, The Chinese journal of physiology.

PCDH8 is Frequently Inactivated by Promoter Hypermethylation in Liver Cancer: Diagnostic and Clinical Significance

C. Zhang, Fan Yang, Wenjun Liu, 2016, Journal of Cancer.

LncRNA MALAT1 regulates METTL3-mediated PD-L1 expression and immune infiltrates in pancreatic cancer

Xiao-Rong Liu, Wenjun Liu, Peter Wang, 2022, Frontiers in Oncology.

Expression profiles of m6A RNA methylation regulators, PD-L1 and immune infiltrates in gastric cancer

Chunye Zhang, Zhiyuan Xu, Wenjun Liu, 2022, Frontiers in Oncology.

The role of lncRNAs in regulation of DKD and diabetes-related cancer

Yujie Xia, Wenjun Liu, Peter Wang, 2022, Frontiers in Oncology.

Epigenetic inactivation of the tumor suppressor gene RIZ1 in hepatocellular carcinoma involves both DNA methylation and histone modifications.

Xiaoying Zhang, Qinghui Zhang, Geng-yin Zhou, 2010, Journal of hepatology.

Early adventitial activation characterized by NADPH oxidase expression and neovascularization in an aortic transplantation model.

F. Jiang, Mengyao Sun, J. Ji, 2016, Experimental and molecular pathology.

KIF2A silencing inhibits the proliferation and migration of breast cancer cells and correlates with unfavorable prognosis in breast cancer

R. Ma, X. Qu, Jianli Wang, 2014, BMC Cancer.

Comparison of the expression of prognostic biomarkers between primary tumor and axillary lymph node metastases in breast cancer.

Lanwei Xu, R. Ma, Haidong Gao, 2015, International journal of clinical and experimental pathology.

Clinical potential of miR-940 as a diagnostic and prognostic biomarker in breast cancer patients.

Wenjun Liu, H. Meng, Hongliang Guan, 2018, Cancer biomarkers : section A of Disease markers.